- Fee assured
- Verified this account
This healthcare professional is currently treating patients. Please speak to them to find out more about their availability.
Last updated: 12 Nov 2020
- Benign Prostate disorders
- General urology
- Urological oncology
Mr. Thomas Lam is Consultant Urological Surgeon and Honorary Senior Clinical Lecturer based at the Department of Urology, Aberdeen Royal Infirmary, and Academic Urology Unit, University of Aberdeen, Scotland. He has a sub-specialist interest in prostate cancer and in robotic radical prostatectomy. Academically, his main areas of interest include clinical trials, evidence-based medicine, evidence synthesis and meta-analysis, clinical practice guideline development, core outcome sets in urological conditions, and methods research. He has published extensively in his areas of interest, having authored more than 200 peer-reviewed publications. He is heavily involved in the development and production of European Association of Urology Clinical Practice Guidelines which issues guidelines to urologists around the world, being a senior panel member of the EAU Prostate Cancer Guideline Panel and EAU Renal Cell Cancer Guideline Panel. He also has a strong track record in undergraduate and postgraduate training and education, being an educational supervisor for medical students, FY2 and CT doctors, and supervisor for PhD and MD students.
Areas of interest
Robotic radical prostatectomy, urinary incontinence, benign prostatic disease, urinary tract infections, painful bladder syndrome
- Linda Smith
- Department of Urology Aberdeen Royal Infirmary Cornhill Road ABERDEEN AB25 2ZN
- 01224 553417
Anaesthetists worked with
Mr Thomas Boon Leong Lam has worked with Dr Ratnasabapathy Kumar at the following hospitals:
- BMI Albyn Hospital (1-5)
Current NHS consultant posts held
Consultant Urological Surgeon, Department of Urology, Ward 209, Aberdeen Royal Infirmary, Foresterhill, Aberdeen AB25 2ZN.
1) Urological cancers including kidney, prostate, bladder, penile and urothelial cancers;
2) Evidence synthesis and meta-analysis;
3) Guideline development;
4) Clinical trials and trial methodology;
5) Methods research;
6) Core outcome set development
Music, sprint triathlon, computing, high fidelity and high definition music, home cinema
(Additional) Languages spoken
- Cantonese - Native or bilingual
- Malay - Native or bilingual
- Indonesian - Fluent
- Chinese - Basic
Lam TBL, MacLennan S, Willemse PPM, et al. EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study). Eur Urol. 2019 (in press).
Albiges L, Powles T, Staehler M, Bensalah K, Giles RH, Hora M, Kuczyk MA, Lam TB, et al. Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma. Eur Urol. 2019 Aug;76(2):151-156.
Van den Broeck T, van den Bergh RCN, Briers E, Cornford P, Cumberbatch M, Tilki D, De Santis M, Fanti S, Fossati N, Gillessen S, Grummet JP, Henry AM, Lardas M, Liew M, Mason M, Moris L, Schoots IG, van der Kwast T, van der Poel H, Wiegel T, Willemse PM, Rouvière O, Lam TB, Mottet N. Biochemical Recurrence in Prostate Cancer: The European Association of Urology Prostate Cancer Guidelines Panel Recommendations. Eur Urol Focus. 2019 Jun 24. pii: S2405-4569(19)30159-2.
Fernández-Pello S, Hora M, Kuusk T, Tahbaz R, Dabestani S, Abu-Ghanem Y, Albiges L, Giles RH, Hofmann F, Kuczyk MA, Lam TB, et al. Management of Sporadic Renal Angiomyolipomas: A Systematic Review of Available Evidence to Guide Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel. Eur Urol Oncol. 2019 Jun 3. pii: S2588-9311(19)30054-9.
Lam TBL, MacLennan S, Plass K, et al. Study Protocol for the DETECTIVE Study: An International Collaborative Study To Develop Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer. European Urology. 2019 Apr;75(4):699-702. doi: 10.1016/j.eururo.2018.11.009. Epub 2018 Nov 22.
Van den Broeck T, Mottet N, Lam T. Reply to Xueliang Zhou and Xinwei Han's Letter to the Editor re: Thomas Van den Broeck, Roderick C.N. van den Bergh, Nicolas Arfi, et al. Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2018.10.011. European Urology. 2019 Apr 6. pii: S0302-2838(19)30255-6.
Courses offered to GPs
Prostate cancer management; benign prostatic disorders; urological infections; management of overactive bladder syndrome.
- MBChB University of Leeds School of Medicine 1997
- MRCSEd Royal College of Surgeons of Edinburgh 2001
- PhD in Surgical Oncology University of Hull 2005
- FRCSEd (Urology) Royal College of Surgeons of Edinburgh 2008
- ORSI Robotic Surgery Certificate ORSI, Belgium 2005
Reference number 4418276
Details of entry to specialist register
- Certificate of Completion of Specialist Training in Urology, 2010
Affiliations / memberships
1) European Association of Urology
2) British Association of Urological Surgeons
3) Fellow of the Royal College of Surgeons of Edinburgh
4) Medical Defence Union
5) British Medical Association
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details